Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidences of Zoonotic Diseases
4.2.2 Initiatives Taken by Various Government Agencies, Animal Associations, and Leading Players
4.2.3 Widened Focus on Food Safety
4.3 Market Restraints
4.3.1 Lack of Veterinarians and Shortage of Skilled Farm Workers
4.3.2 High Storage Costs for Vaccines
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Bovine Vaccine
5.1.2 Poultry Vaccine
5.1.3 Porcine Vaccine
5.1.4 Other Livestock Vaccines
5.2 By Technology
5.2.1 Live Attenuated Vaccine
5.2.2 Inactivated Vaccine
5.2.3 Toxoid Vaccine
5.2.4 Recombinant Vaccine
5.2.5 Other Technologies
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 AniCon Labor GmbH
6.1.2 Animal Science Products Inc.
6.1.3 Biovac
6.1.4 Boehringer Ingelheim International GmbH
6.1.5 ADL BIONATUR SOLUTIONS, S.A.
6.1.6 Ceva Sante Animale
6.1.7 Elanco
6.1.8 Merck & Co.
6.1.9 Phibro Animal Health Corporation
6.1.10 Zoetis Inc


7 MARKET OPPORTUNITIES AND FUTURE TRENDS